These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26125784)

  • 21. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.
    Hussain S; M Y; Thakur N; Salam I; Singh N; Mir MM; Bhat MA; Siddiqi MA; Das BC; Bharadwaj M
    Mol Carcinog; 2011 Jul; 50(7):487-98. PubMed ID: 21268129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis.
    Zhao Y; He HR; Wang MY; Ren XD; Zhang L; Dong YL; Lu J
    Genet Mol Res; 2015 May; 14(2):5171-80. PubMed ID: 26125710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
    Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
    Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
    Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
    Hu YY; Zheng R; Guo C; Niu YM
    Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between
    Thakur N; Kumari S; Mehrotra R
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
    Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
    Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
    Naidu R; Yip CH; Taib NA
    Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ozdil B
    Cancer Epidemiol; 2010 Jun; 34(3):298-302. PubMed ID: 20347627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population.
    Zhang J; Li Y; Wang R; Wen D; Sarbia M; Kuang G; Wu M; Wei L; He M; Zhang L; Wang S
    Int J Cancer; 2003 Jun; 105(2):281-4. PubMed ID: 12673692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
    Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
    DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore.
    Ceschi M; Sun CL; Van Den Berg D; Koh WP; Yu MC; Probst-Hensch N
    Carcinogenesis; 2005 Aug; 26(8):1457-64. PubMed ID: 15845652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.
    Zhang LQ; Huang XE; Wang J; Shang JQ; Bai J; Liu FY; Guan X; Zhou JN
    Asian Pac J Cancer Prev; 2011; 12(1):81-5. PubMed ID: 21517236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
    Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
    Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation analysis of G870A CCND1 gene polymorphism with digestive system tumors].
    Yang SM; Shi YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
    Tan XL; Nieters A; Kropp S; Hoffmeister M; Brenner H; Chang-Claude J
    Int J Cancer; 2008 Jun; 122(11):2573-80. PubMed ID: 18196581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women.
    Jeon YT; Kim JW; Song JH; Park NH; Song YS; Kang SB; Lee HP
    Cancer Lett; 2005 Jun; 223(2):259-63. PubMed ID: 15896460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
    Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S
    Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.